ICU superbug study aims to protect vulnerable patients
NCT ID NCT06652126
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will observe 1,000 critically ill patients in European ICUs to see if those with weakened immune systems are more or less likely to pick up drug-resistant bacteria. Researchers want to understand if current isolation measures are working and how to better control the spread of these dangerous germs. The goal is to improve antibiotic use and infection prevention for all ICU patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICALLY ILL PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
chu de Lille
RECRUITINGLille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.